Aptus Pharma Stock Screener | Share Price & Fundamental Analysis
APPL
Household Appliances
Track Aptus Pharma share price live with TickJournal's free stock screener.
Browse APPL financial statements to support your investment research.
Record your trades in TickJournal's free trading journal and track your portfolio performance.
Aptus Pharma Market Cap
₹236.70 Cr.
APPL P/E Ratio (TTM)
-
Aptus Pharma P/B Ratio
11.84
EPS (TTM)
₹6.37
Dividend Yield
-
Debt to Equity
1.79
APPL 52 Week High
-
Aptus Pharma 52 Week Low
-
Operating Margin
-
Profit Margin
-
APPL Revenue (TTM)
-
EBITDA
-
Net Income
-
Total Assets
₹22.00
Total Equity
₹7.00
Aptus Pharma Share Price History - Stock Screener Chart
Screen APPL historical share price movements with interactive charts. Analyze price trends and patterns.
Aptus Pharma Company Profile - Fundamental Screener
Screen Aptus Pharma company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for APPL shares.
Sector
Consumer Goods
Industry
Household Appliances
Sub-Sector
Household Appliances
Segment
E
ISIN
INE15XJ01010
Aptus Pharma Balance Sheet Screener
Screen APPL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 |
|---|---|---|---|
| Assets | |||
| Total Assets | 22 | 10 | 6 |
| Current Assets | 20 | 8 | 6 |
| Fixed Assets | 1 | 1 | 1 |
| Liabilities | |||
| Total Liabilities | 0 | 0 | 0 |
| Current Liabilities | 3 | 4 | 2 |
| Non-Current Liabilities | 0 | 0 | 0 |
| Shareholders' Equity | |||
| Total Equity | 7 | 2 | 1 |
| Share Capital | 5 | 0 | 0 |
| Reserves & Surplus | 2 | 2 | 1 |
Aptus Pharma Income Statement Screener - Profit & Revenue Analysis
Screen Aptus Pharma income statement and profit fundamentals.
Analyze APPL quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Aptus Pharma share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March |
|---|---|---|---|---|
| Revenue | 0 | 25 | 18 | 14 |
| Expenses | 0 | 20 | 16 | 13 |
| EBITDA | 0 | 5 | 2 | 1 |
| Operating Profit % | 0.00% | 20.00% | 9.00% | 4.00% |
| Depreciation | 0 | 0 | 0 | 0 |
| Interest | 0 | 1 | 0 | 0 |
| Profit Before Tax | 0 | 4 | 1 | 0 |
| Tax | 0 | 1 | 0 | 0 |
| Net Profit | 0 | 3 | 1 | 0 |
| EPS | 0.00 | 6.37 | 5.32 | 1.30 |
Aptus Pharma Cash Flow Screener - Liquidity Fundamentals
Screen APPL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March |
|---|---|---|---|
| Operating Activities | -2 | -2 | 0 |
| Investing Activities | -1 | 0 | 0 |
| Financing Activities | 7 | 3 | 1 |
| Net Cash Flow | 4 | 0 | 0 |
Aptus Pharma Shareholding Pattern Screener
See Aptus Pharma shareholding pattern with promoter, FII, and DII holdings.
Check Aptus Pharma promoter holding and ownership changes for APPL on TickJournal.
| Item | 2025-Jun | 2025-Sept | 2025-Dec |
|---|---|---|---|
| Promoter Holding | 72.89% | 72.89% | 72.89% |
| FII Holding | 10.03% | 10.03% | 0.00% |
| DII Holding | 2.80% | 2.80% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% |
| Public Holding | 11.55% | 11.55% | 22.97% |
| Other Holding | 2.74% | 2.74% | 4.14% |
| Shareholder Count | 9 | 9 | 302 |
Aptus Pharma Share Dividend Screener - Share Yield Analysis
Check Aptus Pharma dividend history with payout and yield data.
View Aptus Pharma dividend details including ex-dates and amounts for APPL stock.
Aptus Pharma Stock Index Membership
See which indices include Aptus Pharma stock.
Check APPL index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Aptus Pharma Market Events Screener - Corporate Actions
Get Aptus Pharma corporate actions including splits, bonuses, and buybacks.
Check Aptus Pharma stock events that may affect APPL share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2025-11-10 | 2025-11-10 | Quarterly Result Announcement | NA | 12.62% |
Aptus Pharma Competitors Screener - Peer Comparison
Screen APPL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| LG Electronics | 89,517 | 53.89 | 24,631 | 14.26% | 2,203 | 29.53 |
| Voltas | 40,878 | 84.05 | 15,737 | 23.58% | 834 | 33.57 |
| Blue Star | 31,424 | 64.78 | 12,043 | 23.73% | 591 | 29.76 |
| Amber Enterprises | 22,106 | 126.28 | 10,047 | 48.08% | 251 | 37.39 |
| Crompton Greaves | 14,933 | 31.68 | 7,932 | 7.48% | 564 | 40.39 |
| V-Guard Industries | 14,094 | 48.02 | 5,599 | 14.48% | 314 | 51.72 |
| Whirlpool | 10,332 | 31.49 | 8,110 | 15.97% | 363 | 44.42 |
| Eureka Forbes | 8,961 | 54.82 | 2,452 | 11.53% | 164 | 49.81 |
| TTK Prestige | 6,074 | 78.02 | 2,790 | 1.31% | 108 | 37.73 |
| Symphony | 5,001 | 31.04 | 1,623 | 34.46% | 213 | 40.10 |
Aptus Pharma Company Announcements - News Screener
Screen APPL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-04-06 | Closure of Trading Window | - |
| 2026-04-05 | Newspaper Advertisement Of Notice Of Postal Ballot And E-Voting Information | - |
| 2026-04-04 | Board Meeting Outcome for Revised Outcome Of Board Meeting Held On 24/03/2026 Incorporating Additional Details In Compliance With SEBI Circular No. SEBI/HO/CFD/Pod2/CIR/P/0155 Dated November 11 2024. | - |
| 2026-04-04 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | - |
| 2026-03-24 | Board Meeting Outcome for Outcome Of Board Meeting Held On March 24 2026 | - |
| 2026-03-17 | Closure of Trading Window | - |
| 2026-03-17 | Board Meeting Intimation for Prior Intimation Of Board Meeting To Be Held On Tuesday March 24 2026 | - |
| 2026-02-26 | Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015: Business Expansion | - |
| 2026-02-24 | Intimation Of Award Received: Recognition As Fastest Growing Ethical Pharma Company | - |
| 2026-02-07 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-01-10 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-12-12 | Press Release- Aptus Pharma Expands OTC Presence In Gujarat Strengthens Cosmeceutical Portfolio | - |
| 2025-11-21 | Regulation 30 Disclosure - Entry Into The Urology Therapy Segment | - |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | - |
| 2025-11-12 | Intimation Of New Product- ENZYKING SYRUP | - |
| 2025-11-12 | Intimation Of New Product- SHIROVITA HAIR OIL (AYURVEDIC HAIR OIL) | - |
| 2025-11-11 | Unaudited Financial Results For The Half Year Ended On 30Th September 2025 | - |
| 2025-11-10 | Unaudited Financial Results For The Half Year Ended On 30Th September 2025 | - |
| 2025-11-10 | Board Meeting Outcome for Board Meeting Outcome For Approval Of Unaudited Financial Results For The Half Year Ended On 30Th September 2025 | - |
| 2025-11-01 | Board Meeting Intimation for To Consider And Take On Record Of The Un-Audited Financial Results For The Half Year Ended On 30Th September 2025. | - |